ATE418994T1 - Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität - Google Patents
Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizitätInfo
- Publication number
- ATE418994T1 ATE418994T1 AT04300830T AT04300830T ATE418994T1 AT E418994 T1 ATE418994 T1 AT E418994T1 AT 04300830 T AT04300830 T AT 04300830T AT 04300830 T AT04300830 T AT 04300830T AT E418994 T1 ATE418994 T1 AT E418994T1
- Authority
- AT
- Austria
- Prior art keywords
- amphetamine
- argone
- neurotoxicity
- treatment
- argon
- Prior art date
Links
- 206010029350 Neurotoxicity Diseases 0.000 title 1
- 206010044221 Toxic encephalopathy Diseases 0.000 title 1
- 230000007135 neurotoxicity Effects 0.000 title 1
- 231100000228 neurotoxicity Toxicity 0.000 title 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 abstract 6
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 abstract 4
- 229960000632 dexamfetamine Drugs 0.000 abstract 4
- 229910052786 argon Inorganic materials 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 239000007789 gas Substances 0.000 abstract 2
- 241000700159 Rattus Species 0.000 abstract 1
- 230000002075 anti-alcohol Effects 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000000648 anti-parkinson Effects 0.000 abstract 1
- 230000002738 anti-smoking effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000000939 antiparkinson agent Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000006742 locomotor activity Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation By Low-Temperature Treatments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0350997A FR2863169B1 (fr) | 2003-12-08 | 2003-12-08 | Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE418994T1 true ATE418994T1 (de) | 2009-01-15 |
Family
ID=34508773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04300830T ATE418994T1 (de) | 2003-12-08 | 2004-12-01 | Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20050152988A1 (de) |
| EP (2) | EP2014293B1 (de) |
| AT (1) | ATE418994T1 (de) |
| DE (1) | DE602004018735D1 (de) |
| DK (1) | DK2014293T3 (de) |
| ES (2) | ES2405953T3 (de) |
| FR (1) | FR2863169B1 (de) |
| PL (1) | PL2014293T3 (de) |
| PT (2) | PT1541156E (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2858233B1 (fr) * | 2003-07-30 | 2008-04-11 | Air Liquide Sante Int | Medicament gazeux inhalable a base de xenon et de protoxyde d'azote |
| FR2863169B1 (fr) * | 2003-12-08 | 2006-02-10 | Air Liquide Sante Int | Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications |
| EP1980260A1 (de) * | 2007-04-10 | 2008-10-15 | Nicholas Peter Franks | Verwendung hyperbarischer Bedingungen zur Bereitstellung von Neuroprotektion |
| EP1980261A1 (de) | 2007-04-10 | 2008-10-15 | Nicholas Peter Franks | Verwendung von Helium mit Sauerstoff zur Bereitstellung von Neuroprotektion |
| CA2685446A1 (en) | 2007-04-30 | 2008-11-06 | Nnoxe Pharmaceutiques Inc. | Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon |
| ITMI20071031A1 (it) * | 2007-05-22 | 2008-11-23 | Acetilene & Deriv Ati Siad Spa | Uso di xenon per la protezione di organi da danno ischemico |
| FR2929513B1 (fr) * | 2008-04-02 | 2010-09-17 | Air Liquide | Traitement des migraines sans aura chez le femmes enceintes par inhalation de dioxygene gazeux. |
| WO2010035074A1 (en) * | 2008-09-25 | 2010-04-01 | Nnoxe Pharmaceutiques Inc | Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents |
| FR2956323B1 (fr) | 2010-02-15 | 2013-12-20 | Air Liquide | Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques |
| FR2960779A1 (fr) | 2010-06-08 | 2011-12-09 | Air Liquide | Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques |
| FR2964036B1 (fr) | 2010-08-24 | 2013-04-12 | Air Liquide | Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications |
| FR2975597B1 (fr) * | 2011-05-24 | 2013-12-27 | Air Liquide | Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes |
| FR2976815A1 (fr) * | 2011-06-27 | 2012-12-28 | Air Liquide | Medicament inhalable a base d'argon pour traiter ou prevenir les dyskinesies |
| FR2996457B1 (fr) * | 2012-10-09 | 2019-11-29 | L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique |
| FR2996459B1 (fr) * | 2012-10-09 | 2015-02-06 | Air Liquide | Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique |
| WO2014093277A1 (en) | 2012-12-11 | 2014-06-19 | The Mclean Hospital Corporation | Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders |
| FR2999082A1 (fr) * | 2012-12-12 | 2014-06-13 | Air Liquide | Utilisation d'argon combine a une hypothermie pour prevenir ou traiter les consequences neurologiques d'une asphyxie perinatale |
| GB201409085D0 (en) * | 2014-05-21 | 2014-07-02 | David Helene N | Argon is a mu opioid receptor antagonist |
| CN107569509B (zh) * | 2017-02-22 | 2018-09-21 | 滨州医学院 | 氙或氙气体混合物在制备治疗癫痫的制剂中的用途 |
| FR3100714A1 (fr) * | 2019-09-12 | 2021-03-19 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Argon associé à une thrombectomie en cas d’accident vasculaire cérébral ischémique |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US584556A (en) * | 1897-06-15 | William a | ||
| SU1179997A1 (ru) * | 1973-02-28 | 1985-09-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср | Средство дл лечени паркинсонизма "глудантан |
| US3876773A (en) * | 1973-05-15 | 1975-04-08 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
| FR2596989B1 (fr) * | 1986-04-14 | 1990-05-18 | Air Liquide | Produit de radiosensibilisation des tissus biologiques en radiotherapie |
| EP0888300A1 (de) * | 1996-03-22 | 1999-01-07 | Neurogen Corporation | Kondensierte pyrrolcarboxamide als gaba-gehirn-rezeptor-liganden |
| US5846556A (en) * | 1996-06-14 | 1998-12-08 | Brooks; Bradley S. | Inhalant for reducing stress and method of use |
| DE19910986C2 (de) * | 1999-03-11 | 2001-06-07 | Aga Ab | Verwendung von Xenon bei der Behandlung von Neurointoxikationen |
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| FR2812545B1 (fr) * | 2000-08-03 | 2003-03-28 | Air Liquide Sante Int | Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur |
| FR2858233B1 (fr) * | 2003-07-30 | 2008-04-11 | Air Liquide Sante Int | Medicament gazeux inhalable a base de xenon et de protoxyde d'azote |
| FR2863169B1 (fr) * | 2003-12-08 | 2006-02-10 | Air Liquide Sante Int | Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications |
-
2003
- 2003-12-08 FR FR0350997A patent/FR2863169B1/fr not_active Expired - Fee Related
-
2004
- 2004-12-01 PL PL08165103T patent/PL2014293T3/pl unknown
- 2004-12-01 AT AT04300830T patent/ATE418994T1/de not_active IP Right Cessation
- 2004-12-01 ES ES08165103T patent/ES2405953T3/es not_active Expired - Lifetime
- 2004-12-01 PT PT04300830T patent/PT1541156E/pt unknown
- 2004-12-01 EP EP08165103A patent/EP2014293B1/de not_active Expired - Lifetime
- 2004-12-01 DK DK08165103.6T patent/DK2014293T3/da active
- 2004-12-01 DE DE602004018735T patent/DE602004018735D1/de not_active Expired - Lifetime
- 2004-12-01 ES ES04300830T patent/ES2320128T3/es not_active Expired - Lifetime
- 2004-12-01 EP EP04300830A patent/EP1541156B1/de not_active Expired - Lifetime
- 2004-12-01 PT PT81651036T patent/PT2014293E/pt unknown
- 2004-12-08 US US11/007,684 patent/US20050152988A1/en not_active Abandoned
-
2007
- 2007-08-09 US US11/836,536 patent/US20070275089A1/en not_active Abandoned
-
2010
- 2010-12-15 US US12/969,190 patent/US20110086107A1/en not_active Abandoned
-
2013
- 2013-09-30 US US14/040,962 patent/US20140120184A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2014293E (pt) | 2013-05-07 |
| US20140120184A1 (en) | 2014-05-01 |
| ES2320128T3 (es) | 2009-05-19 |
| EP1541156A1 (de) | 2005-06-15 |
| US20070275089A1 (en) | 2007-11-29 |
| FR2863169B1 (fr) | 2006-02-10 |
| DK2014293T3 (da) | 2013-05-13 |
| FR2863169A1 (fr) | 2005-06-10 |
| PT1541156E (pt) | 2009-04-01 |
| DE602004018735D1 (de) | 2009-02-12 |
| EP1541156B1 (de) | 2008-12-31 |
| PL2014293T3 (pl) | 2013-07-31 |
| US20050152988A1 (en) | 2005-07-14 |
| US20110086107A1 (en) | 2011-04-14 |
| ES2405953T3 (es) | 2013-06-04 |
| EP2014293B1 (de) | 2013-03-13 |
| EP2014293A1 (de) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE418994T1 (de) | Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| BR0313282A (pt) | Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia | |
| DE502007002101D1 (de) | Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| EP1365778A4 (de) | Behandlung von lungenerkrankungen mit gasförmigem mittel, das zur verarmung von gsno führt | |
| DE59508360D1 (de) | Liposomal verkapseltes taxol, seine herstellung und seine verwendung | |
| TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| WO2005113026A3 (en) | Method of treating respiratory disorders and airway inflammation | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
| EP2392322A3 (de) | Dosierschemata für Trans-Clomiphen | |
| NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| IL170519A (en) | Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them | |
| PT1572686E (pt) | Derivados de amida do ácido antranílico e suas utilizações farmacêuticas | |
| DE60202299D1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
| TW200505427A (en) | A solid oral dosage form of metformin and glyburide and the method of preparation thereof | |
| PL375354A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
| WO2007095605A3 (en) | Method for accelerating reentrainment of a circadian rhythm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |